Business
Sanofi Supports AlphaDetect to Accelerate Detection of Alpha-1
AlphaDetect, the nonprofit organization powered and funded by the Alpha-1 Foundation, today announced Sanofi as one of its inaugural industry sponsors. This support further strengthens efforts to accelerate routine detection of Alpha-1 Antitrypsin Deficiency (Alpha-1), consistent with clinical practice guidelines.
About this update from Sanofi Sa
[{"type":"text","content":"The sponsorship helps expand proven Alpha-1 detection strategies, which will enable earlier patient identification","length":114,"tagName":"p"},{"type":"text","content":"DURHAM, N.C., May 6, 2026 /PRNewswire/ -- AlphaDetect, the nonprofit organization powered and funded by the Alpha-1 Foundation, today announced Sanofi as one of its inaugural industry sponsors. This support further strengthens efforts to accelerate routine detection of Alpha-1 Antitrypsin Deficiency (Alpha-1), consistent with clinical practice guidelines.","length":357,"tagName":"p"},{"type":"image","alt":"AlphaDetect Trademark","displaySize":"","headline":null,"caption":"AlphaDetect Trademark","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":103,"url":"https://media.zenfs.com/en/prnewswire.com/53e8e7ad7a4ba9ad8fb48bdd5e24fdbb"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Xc6eOAerPfz9Tv0Yufjlzw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE4Mg--/https://media.zenfs.com/en/prnewswire.com/53e8e7ad7a4ba9ad8fb48bdd5e24fdbb","width":400,"height":103},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/T2oHSEil3AZUNH6eNyDWKA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTE2NQ--/https://media.zenfs.com/en/prnewswire.com/53e8e7ad7a4ba9ad8fb48bdd5e24fdbb","width":400,"height":103}},"href":"https://mma.prnewswire.com/media/2973906/AlphaDetect_Trademark_Logo_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"AlphaDetect is dedicated to identifying everyone at risk for this progressive, genetic condition by elevating awareness, removing barriers, and expanding adoption of testing recommendations in clinical practice guidelines, so that Alpha-1 detection becomes routine for patients impacted by lung and liver disease. The organization is increasing the availability of Alpha-1 detection tools and support at the practice level while partnering with healthcare providers to strategically advance protocols and technologies across healthcare systems.","length":544,"tagName":"p"},{"type":"text","content":""Sanofi is proud to support AlphaDetect's mission, as one of the inaugural sponsors, to increase and accelerate Alpha-1 detection," said Alaa Hamed, Global Head of Medical Affairs, Rare Diseases at Sanofi. "This effort represents a meaningful step forward in uncovering those at risk for this extremely underdiagnos...